Problem Page · Beyond Brain Health™

Postoperative Cognitive
Dysfunction (POCD)

Clinical definitions, prevalence data, the Lancet Commission evidence base, risk factor analysis, what standard care measures and does not measure — and the measurement response.

AuthorSandra Bargeron, PA-C, CAA
Dataset2,062 NSRI™ completers
Risk Factors Identified73 (umbrella review)
AudiencePatients & Clinicians
Clinical Definition

Clinical Definition
and Nomenclature

POCD is defined as a measurable decline in cognitive ability — affecting memory, attention, processing speed, and executive function — that persists beyond the immediate recovery period following surgery and anesthesia.

It is more subtle than postoperative delirium, but no less disruptive to the patient. It is clinically distinct from postoperative delirium (POD), which is an acute confusional state typically occurring within the first hours to days postoperatively, though the two conditions share risk factors and frequently co-occur.

In 2018, an international Nomenclature Consensus Working Group established standardized definitions for the full spectrum of perioperative neurocognitive disorders (PND).

Evered L et al.; Nomenclature Consensus Working Group. Br J Anaesth. 2018;121(5):1005-1012. [Ref 4, Landmark]
Prevalence

How Common Is POCD?

More common than most patients and clinicians recognize — and the numbers get worse at higher surgical risk.

Day 7
0%
of older non-cardiac surgical patients
Vlisides P et al. Maturitas, 2025
1 Month
0%
of older non-cardiac surgical patients
Vlisides P et al. Maturitas, 2025
3 Months
0%
of older non-cardiac surgical patients
Vlisides P et al. Maturitas, 2025
Post-CABG
30–60%
notice cognitive changes in the first weeks after coronary bypass
Greaves D et al. Int J Cardiology, 2019 (n=91,829)
Delirium → Dementia
more likely to develop dementia after even a single episode of surgical delirium
Gordon EH et al. BMJ, 2024
Risk Factors
0
distinct risk factors identified by umbrella review of meta-analyses
Taffett NT et al. J Clin Med, 2023

Delirium duration is an independent predictor of 6-month mortality. These are not abstract statistics — they are the clinical reality entering every OR every day.

Marcantonio ER. N Engl J Med. 2017;377(15):1456-1466. [Ref 12, Landmark]
The Evidence Foundation

The Lancet Commission — 2024

A brain entering surgery already depleted across modifiable domains is not starting from zero. It's starting in deficit.

The 2024 Lancet Commission on Dementia Prevention, Intervention, and Care identified 14 modifiable risk factors accounting for approximately 45% of dementia cases worldwide.

The Commission's evidence directly defines the preventable fraction of perioperative cognitive morbidity: these same modifiable factors determine a brain's resilience under the neurologic stress of anesthesia. The perioperative period is when The Lancet's findings become immediately, clinically actionable — a surgery date is the deadline.

Livingston G et al. Lancet. 2024;404(10452):572-628. [Ref 1, Landmark]
Livingston G et al. Lancet. 2020;396(10248):413-446. [Ref 2]
Livingston G et al. Lancet. 2017;390(10113):2673-2734. [Ref 3]
Risk Factor Analysis

Who Is at Risk: The Evidence Base

A 2023 umbrella review identified 73 distinct risk factors associated with perioperative cognitive complications. Age is the most consistent predictor — but risk is neither uniformly distributed among older adults nor limited to them.

Prior Surgical Delirium — The Dominant Clinical Finding

In the NSRI™ research window dataset (n=2,062), prior surgical delirium history is the single strongest predictor of elevated Bottleneck Index (r=0.727 vs BI; p=5.96×10⁻²³⁵). Participants with a history of delirium have a mean Bottleneck Index of 0.516 vs 0.186 in those without — nearly 3× higher.

What makes this finding alarming isn't the 34%. It's that most of these patients were never told they had delirium. They woke up confused and were told it was "just the anesthesia." Their patient record then failed to capture the patient's actual clinical experience.

Prior delirium is substantially under-documented in standard care. The 34.0% prevalence in the NSRI™ dataset likely represents a conservative floor — most patients who experienced post-surgical confusion were never given the diagnosis. Standard preoperative intake would not capture this history at all.

Inouye SK et al. Lancet. 2014;383(9920):911-922. [Ref 10, Landmark]
Rudolph JL, Marcantonio ER. Anesth Analg. 2011;112(5):1202-1211. [Ref 19]
34.0%
Prior delirium history in NSRI™ completers
r=0.727
Strongest Bottleneck predictor (p=5.96×10⁻²³⁵)
−13.5 pts
Mean NSRI score gap: 56.9 (delirium present) vs 70.5 (absent)
2.17×
Co-occurrence rate of delirium + anesthesia reactions (p<0.001)
NSRI™ Population Data

The High-Risk Cohort:
A Distinct Clinical Profile

The 89 completers scoring below 40 on the NSRI™ (4.3% of the research window population) represent a clinically distinct profile — not simply a more burdened version of the average participant.

Metric
High-Risk Cohort
NSRI <40 (n=89)
Full Population
(n=2,062)
Mean final NSRI score
33.2
65.9
Mean Bottleneck Index
0.713
0.298 (2.39× lower)
4+ Bottleneck factors
~82%
36.9%
TBI / head injury history
93.3%
69.2%
Prior surgical delirium
84.3%
34.0%
Anesthesia reactions
83.1%
31.5%
Functional frailty
69.7%
22.0% (3.17× rate)
Connective tissue / autonomic
56.2%
18.6% (3.02× rate)
Source: NSRI™ V2.5 Research Window Dataset — 2,062 completers, research window closed March 19, 2026. Sandra Bargeron, PA-C, CAA · Beyond Brain Health™

These individuals represent the highest-need sub-population for preoperative neurologic optimization. Near-universal TBI history, prior delirium, and anesthesia reactions converge with high frailty and connective tissue/autonomic burden.

This is a convergence pattern that standard preoperative intake has no mechanism to detect.

A Counterintuitive Finding

Age: What the Data Shows

Conventional medicine predicts a decline in neurologic resilience with advancing age. The NSRI™ research window data does not show this pattern.

Mean NSRI scores are nearly flat across all age bands (range 61.5–66.9, with no meaningful gradient from under-50 through age 85+). The 65–69 band, the largest single age group in the dataset (n=415, 20.1%), has the highest mean score of any group: 66.8.

Two things can be true at the same time: (1) The NSRI™ Bottleneck approach spots neurologic risk in ways that don't depend on age — catching things that age alone might miss. (2) The older people in this group may be especially health-conscious, which could skew results. Both ideas are included here to maintain intellectual and research integrity.

The Structural Gap

What Standard Care Measures —
and Does Not Measure

Standard preoperative assessment was designed to keep patients alive during surgery. That's what it does well. Brain state going in was never part of the mandate.

What Standard Care Measures
What Standard Care Does Not Measure
Cardiovascular and pulmonary function
Neurologic reserve across five modifiable domains
Medication list (reconciliation)
Compound pharmacologic burden's effect on neurologic resilience
Existing cognitive impairment (MoCA, MMSE)
Vulnerability to future cognitive decline from surgical stress
Surgical risk category (ASA classification)
Brain state at the time of anesthetic exposure
Anesthesia type and drug selection
Modifiable factors that could be strengthened before surgery to change the outcome
Prior delirium history (34.0% of surgical-age population; captured by NSRI™ H1)
Prior anesthesia reaction history (31.5%; NSRI™ H6)
TBI and subconcussive head impact history (69.2%; NSRI™ H2)
Neuroinflammatory infection history (NSRI™ H10, V2.5)

What Is Changing

The ASA Brain Health Initiative (2019) formally established perioperative brain health as a clinical priority. The APSF reinforced delirium prevention as a patient safety priority in 2024. The European Society of Anaesthesiology issued evidence-based guidelines on postoperative delirium in 2017.

The emerging field of perioperative brain optimization can now respond to this call by conducting domain-specific, modifiable-factor assessments before surgery. The operative distinction: the goal is optimization, not prediction.

The NSRI™ does not predict who will decline — it quantifies what can be strengthened.

Aldecoa C et al. Eur J Anaesthesiol. 2017;34(4):192-214. [Ref 17]
Hughes CG et al. Anesth Analg. 2020;130(6):1572-1590. [Ref 18]
The Measurement Response

73 risk factors. 34% carry
undetected delirium history.
None of it captured by standard care.

0%carry TBI history
0%carry ≥1 Bottleneck factor
0%prior surgical delirium

The NSRI™ — developed by Sandra Bargeron, PA-C, CAA — is the measurement tool designed to close that gap.

Reference Library

Full Reference List

Key studies cited on this page. Full library at beyondbrainhealth.com/nsri-evidence.

Landmark Studies 8
  1. [1] Livingston G et al. Lancet. 2024;404(10452):572-628.
  2. [2] Livingston G et al. Lancet. 2020;396(10248):413-446.
  3. [3] Livingston G et al. Lancet. 2017;390(10113):2673-2734.
  4. [4] Evered L et al. Br J Anaesth. 2018;121(5):1005-1012.
  5. [10] Inouye SK et al. Lancet. 2014;383(9920):911-922.
  6. [12] Marcantonio ER. N Engl J Med. 2017;377(15):1456-1466.
  7. [54] Gray SL et al. JAMA Intern Med. 2015;175(3):401-407.
  8. [58] Billioti de Gage S et al. BMJ. 2014;349:g5205.
Prevalence & Nomenclature 5
  1. [6] Vlisides P, Bhattacharya S. Maturitas. 2025;194:108148.
  2. [7] Taffett NT et al. J Clin Med. 2023;12(4):1610.
  3. [19] Rudolph JL, Marcantonio ER. Anesth Analg. 2011;112(5):1202-1211.
  4. [72] Bellelli G et al. J Am Geriatr Soc. 2014;62(7):1335-1340.
  5. [140] Greaves D et al. Int J Cardiology. 2019;289:43-49.
Cardiometabolic Risk 3
  1. [87] Chen Y et al. Front Aging Neurosci. 2019;11:197.
  2. [88] Feinkohl I et al. Br J Anaesth. 2023;131(2):338-347.
  3. [91] Rundshagen I et al. BMC Anesthesiol. 2019;19(1):36.
Medication & Pain Burden 4
  1. [61] Jiang X et al. Anesthesiology. 2025;143(6):1560-1571.
  2. [107] Crowe SF, Stranks EK. Arch Clin Neuropsychol. 2018;33(7):901-911.
  3. [115] Khaled M et al. Br J Anaesth. 2025;134(1):89-101.
  4. [133] Terrando N et al. Ann Neurol. 2011;70(6):986-995.
TBI, Frailty & Delirium 5
  1. [17] Aldecoa C et al. Eur J Anaesthesiol. 2017;34(4):192-214.
  2. [18] Hughes CG et al. Anesth Analg. 2020;130(6):1572-1590.
  3. [22] Gu D et al. Neuroepidemiology. 2022;56(1):4-16.
  4. [71] Fried LP et al. J Gerontol A. 2001;56(3):M146-156.
  5. [128] Khan A et al. Biology (Basel). 2025;14(6):640.